Cowen initiated coverage on CTI BioPharma with a new price target
$CTIC
Biotechnology: Pharmaceutical Preparations
Health Care
Cowen initiated coverage of CTI BioPharma with a rating of Outperform and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/17/2022 | $13.00 | Outperform | SVB Leerink |
| 9/1/2022 | $13.00 | Buy | Jefferies |
| 7/7/2022 | $10.00 | Outperform | Cowen |
| 3/2/2022 | $4.00 → $5.00 | Market Outperform | JMP Securities |
| 3/2/2022 | $5.00 → $8.00 | Buy | Needham |
| 12/1/2021 | $6.00 → $5.00 | Buy | Needham |
| 8/9/2021 | $7.00 | Buy | BTIG Research |